Bio-Works Technologies
Bio-Works receives a Letter of Intent (LOI) - the anticipated order value is €652,000.
REG
This LOI marks a pivotal step toward reinforcing Bio-Works' relationship with our customers in the biopharmaceutical industry. Bio-Works' WorkBeads affimAb product has shown exceptional value in high-stakes manufacturing environments, with data from multiple manufacturing sites affirming its performance.
"We are thrilled about the potential of this order, as it underscores the trust and value placed in Bio-Works' products by industry leaders" said Lone Carlbom, CEO of Bio-Works. "This LOI is a testament to our commitment to quality and innovation, and we look forward to further strengthening our partnerships across the biopharmaceutical sector."
| Datum | 2024-11-04, kl 08:37 |
| Källa | Cision |
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 15 000 unika besökare per månad. Vår discord har över 6000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!